Latest Rodenticides Stories
The revelations come amid a growing number of Xarelto lawsuits that, among other things, question the marketing tactics used to drive sales of the blood thinner. New
Anticoagulation Coalition Electronic Health Record Task Force provides List of EHR features for the delivery of optimized anticoagulation therapy ST. PAUL, Minn., Nov.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, deep vein thrombosis, pulmonary embolism, and other serious complications, allegedly
A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C.
The Firm is investigating Xarelto lawsuits on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, or pulmonary embolism due to the blood thinner.
RnRMarketResearch.com adds "Rodenticides Market by Type (Anticoagulants, Non-Anticoagulants, and Others), by End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers, and Others)
Rodent control market leader reaches agreement with U.S.
IPRO-designed "MAP" Tool Addresses How to Handle Numerous Patient Situations, In Order to Reduce Risk of Both Excessive Bleeding and Formation of Blood Clots LAKE SUCCESS, N.Y., May
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
Recently Released ACC/AHA Practice Guidelines Reinforce Unmet Need MENLO PARK, Calif., April 29, 2014 /PRNewswire/ -- Armetheon, Inc., today announced that it has reached agreement
- The word or words serving to define another word or expression, as in a dictionary entry.